Gen Z wants their job to cover GLP-1 weight-loss drugs, survey suggests

"A new ZipHealth survey of over 1,000 workers found that nearly half (47%) of Gen Z said GLP-1 coverage would affect their choices between two similar jobs."

"Overall, the majority (54%) of workers said they would give up at least one workplace perk for employer-covered GLP-1 treatment."

"GLP-1 drugs like Wegovy and Ozempic have completely changed the game when it comes to weight-loss or diabetes management, moving from celebrity circles to the mainstream."

"The majority of workers surveyed by ZipHealth said GLP-1 medication coverage should be a standard benefit."

Gen Z is increasingly considering employer coverage of GLP-1 weight-loss drugs when evaluating job offers. A ZipHealth survey revealed that 47% of Gen Z workers would choose a job based on GLP-1 coverage, compared to lower percentages in older generations. Additionally, 9% of Gen Z would accept a pay cut for such coverage. Overall, 54% of workers would sacrifice a workplace perk for GLP-1 treatment, indicating a shift in workplace benefit priorities. The popularity of GLP-1 drugs has surged, prompting calls for their inclusion as standard employee benefits.

Read at Fast Company